Catalyst

Slingshot members are tracking this event:

Top-line results of Phase 3 long-term safety and tolerability study ETC-1002-040 of bempedoic acid in patients with hyperlipidemia whose LDL-C is not adequately controlled with low- and moderate-dose statins expected in Q2 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ESPR Community voting in process

Additional Information

Additional Relevant Details Oct 2 2017 Update: Completed patient enrollment
http://investor.espe...
http://investor.espe...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 07, 2018
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Ldl-c, Cholesterol Lowering, Etc-1002, Acl-inhibiting Regimen, Clear, Bempedoic Acid, Hyperlipidemia